Used in the treatment of several types of cancer, including differentiated thyroid cancer, advanced renal cell carcinoma, and hepatocellular carcinoma. It functions as a multi-kinase inhibitor, blocking key proteins involved in tumor angiogenesis, growth, and progression. Also approved for use in combination with other therapies, such as everolimus or pembrolizumab, to enhance efficacy in advanced kidney and endometrial cancers. Its targeted action helps slow tumor growth and improve progression-free survival in patients with specific genetic and tumor profiles.